SM

Scott Megaffin

Chief Executive Officer

Adastra Pharmaceuticals, Inc.

New York, New York


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Adastra Pharmaceuticals, Inc.
Industry
pharmaceuticals
Employees
50.0
Seniority
C suite
Annual Revenue
9500000.0
Total Funding
26771559.0
Latest Funding
Other

Technologies

Outlook GoDaddy Hosting Apache Mobile Friendly

Keywords

pharmaceutical manufacturing cancer treatment multi-kinase inhibitor cdk9 inhibition oncogenic protein myc high-grade gliomas tumor growth inhibition apoptosis induction glutamine metabolism tumor heterogeneity targeted therapy drug delivery blood-brain barrier pharmacological targets safety profile clinical development oncogene targeting rna polymerase ii inhibition tumorigenesis precision medicine tumor cell death systemic drug levels genetic screening compensatory mechanisms cancer drug resistance dose optimization patient stratification therapeutic efficacy metabolic activity reduction tumor microenvironment molecular profiling glioma subtypes antiapoptotic proteins tissue penetration clinical trials biomarker identification tumor biology glucose dependency treatment resistance therapeutic targeting tumor metabolism oncocytogenesis malignant transformation cancer therapeutics cellular proliferation histology segmentation pharmaceuticals medical health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans